Cardiac safety of trastuzumab without an anthracycline in patients with HER2-positive early stage breast cancer: A single center experience

被引：0
|
作者：
Mukku, R. B. [1 ]
Verma, S. [1 ]
Liu, J. [1 ]
Steingart, R. [1 ]
Hudis, C. [1 ]
Yu, A. F. [1 ]
Dang, C. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-14-09
引用
收藏
页数：1
相关论文
共 50 条
  • [31] CARDIAC SAFETY OF THE TRASTUZUMAB BIOSIMILAR ABP 980 IN WOMEN WITH HER2-POSITIVE EARLY BREAST CANCER IN THE LILAC STUDY
    Kolberg, H-C
    Colleoni, M.
    Demetriou, G. Sawa
    Santi, P.
    Tesch, H.
    Fujiwara, Y.
    Tomasevic, Z.
    Hanes, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A55 - A55
  • [32] Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients
    Mustacchi, G.
    Puglisi, F.
    Molino, A. M.
    Crivellari, D.
    Ghiotto, C.
    Ferro, A.
    Brunello, A.
    Saracchini, S.
    Turazza, M.
    Cretella, E.
    Iop, A.
    Malagoli, M.
    Stefani, M.
    FUTURE ONCOLOGY, 2015, 11 (10) : 1493 - 1500
  • [33] Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experience
    Hall, Benjamin James
    Bhojwani, Ajay Ashok
    Wong, Helen
    Law, Andrea
    Flint, Helen
    Ahmed, Eliyaz
    Innes, Helen
    Cliff, Joanne
    Malik, Zaf
    O'Hagan, Julie Elizabeth
    Hall, Allison
    Sripadam, Rajaram
    Tolan, Shaun
    Ali, Zulfiqar
    Hart, Clare
    Errington, Douglas
    Alam, Farida
    Giuliani, Rosa
    Mehta, Shaveta
    Khanduri, Sheena
    Thorp, Nicky
    Jackson, Richard
    Cicconi, Silvia
    Palmieri, Carlo
    BREAST JOURNAL, 2022, 2022
  • [34] Trastuzumab-related subclinical cardiotoxicity in patients with early stage HER2-positive breast cancer: A retrospective single-center cohort study.
    Aseyev, Olexiy
    Rushton-Marovac, Moira
    Crawley, Freya L.
    Johnson, Christopher
    Dent, Susan Faye
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] A Phase II Preoperative Trial of Concurrent Trastuzumab and Paclitaxel without Anthracycline in HER2-Positive Operable Breast Cancer
    Sato, T.
    Hayashida, T.
    Takahashi, M.
    Sakata, M.
    Jinno, H.
    Hirose, S.
    Mukai, M.
    Kitagawa, Y.
    CANCER RESEARCH, 2010, 70
  • [36] Subcutaneous trastuzumab - recent evidence on efficacy and safety in HER2-positive breast cancer patients
    Pogoda, Katarzyna
    Niwinska, Anna
    ONCOLOGY IN CLINICAL PRACTICE, 2015, 11 (02): : 93 - 99
  • [37] Trastuzumab Use Modest in Patients With HER2-Positive Breast Cancer
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (05) : 339 - 339
  • [38] Safety Evaluation of Trastuzumab Emtansine in Japanese Patients with HER2-Positive Advanced Breast Cancer
    Watanabe, Junichiro
    Ito, Yoshinori
    Saeki, Toshiaki
    Masuda, Norikazu
    Takano, Toshimi
    Takao, Shintaro
    Nakagami, Kazuhiko
    Tsugawa, Koichiro
    Nakagawa, Shintaro
    Kanatani, Kazumitsu
    Nakayama, Takahiro
    IN VIVO, 2017, 31 (03): : 493 - 500
  • [39] Adjuvant Trastuzumab in HER2-Positive Breast Cancer
    Slamon, Dennis
    Eiermann, Wolfgang
    Robert, Nicholas
    Pienkowski, Tadeusz
    Martin, Miguel
    Press, Michael
    Mackey, John
    Glaspy, John
    Chan, Arlene
    Pawlicki, Marek
    Tamas Pinter
    Valero, Vicente
    Liu, Mei-Ching
    Sauter, Guido
    von Minckwitz, Gunter
    Visco, Frances
    Bee, Valerie
    Buyse, Marc
    Bendahmane, Belguendouz
    Tabah-Fisch, Isabelle
    Lindsay, Mary-Ann
    Riva, Alessandro
    Crown, John
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14): : 1273 - 1283
  • [40] Efficacy and safety of eribulin in combination with trastuzumab in HER2-positive metastatic breast cancer patients: Real life experience
    Kovalenko, E.
    Manzyuk, L.
    Gorbunova, V.
    Kolyadina, I.
    Bolotina, L.
    Zhilyaeva, L.
    Ponomarenko, D.
    Karabina, E.
    Mukhametshina, G.
    Khasanova, A.
    Ekaterina, R.
    Safarova, A.
    Manikhas, A.
    Volkonsky, M.
    Kramskaya, L.
    Karandeeva, T.
    Suslova, I.
    Popova, N.
    Evstigneeva, I.
    Shumskaya, I.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S59 - S59
12345